No Detail Found!

Comparison of Efficacy of Intranasal Midazolam and Conventional Treatment with Intravenous Diazepam for Control of Seizures in Children; A Randomized Controlled Trial

Author(s)
Zunash Fateh The Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
Nighat Haider Shaheed Zulfiqar Ali Bhutto University, PIMS, Islamabad, Pakistan
Jai Krishin The Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
Sadia Riaz The Children Hospital, PIMS, Islamabad, Pakistan
Muqadar Shah The Children Hospital, PIMS, Islamabad, Pakistan
Saad Abdullah Fateh Adam University School of Medicine, Pakistan
Abstract
To compare the efficacy of intranasal midazolam and conventional treatment with intravenous diazepam for the control of seizures in children. Methodology: It was a randomized controlled trial registration no NCT04885075 conducted in the Children Hospital, PIMS, Islamabad from January 2022 to June 2022 presenting to the ER department with seizures. The patients were randomly divided into two groups. Group A patients were given a single dose of intranasal midazolam (0.2 mg/kg). Group B patients were treated with a single dose of intravenous Diazepam (0.2mg/kg). We recorded the following parameters: 1) the period elapsed between arrival at emergency and drug administration. 2) The time interval between drug administration and cessation of seizures. 3) The period between admission to the hospital and the end of seizures. Results: Among 60 enrolled patients, there were thirty-one males and twenty-nine females. The mean age of the patient was 5.27 ± 3.31 years. The mean intervals between arrival at the hospital and treatment given were 3.00±0.91 and 7.03±2.91 mins (p-value 0.000) in groups A and B, respectively. The mean intervals between the treatment given and cessation of seizure were 2.70 ± 1.05 and 2.60 ± 1.13 mins (p-value 0.725) in groups A and B, respectively. The mean intervals between arrival at the hospital and the cessation of seizure were 5.70 ± 1.3 and 9.63 ± 2.58 mins (p-value 0.000) in groups A and B, respectively. Conclusion: The intranasal Midazolam was shown to be as effective in suppressing seizure as the intravenous Diazepam. This is the best option if you don't have access to an intravenous line.
Publication Details
Page(s) 274-278
Published Journal: Annals of the Pakistan Institute of Medical Sciences, Volume: 18, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
Intravenous, Intranasal, Diazepam, Midazolam, Status epilepticus., Acute Seizures
0

Citations

0

Downloads

64

Views